CD274 and neoplasm: Indeed, the density and location of immune cells in the tumor microenvironment have led to establishing the concept of “cold” immune desert tumors, which are not eligible and not responding to ICBs, and “hot” inflamed immune infiltrated PD‐L1 expressed tumors, which are eligible and responding to ICBs.6